UK markets closed

Sunho Biologics Inc (2898.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
6.700-0.200 (-2.90%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 1.05B
Enterprise value 828.84M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.59k
Price/book (mrq)N/A
Enterprise value/revenue 3.63k
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-53.86%
S&P500 52-week change 323.76%
52-week high 315.420
52-week low 36.700
50-day moving average 38.178
200-day moving average 38.178

Share statistics

Avg vol (3-month) 3595.06k
Avg vol (10-day) 3207.87k
Shares outstanding 5156.67M
Implied shares outstanding 6156.67M
Float 833.17M
% held by insiders 169.53%
% held by institutions 110.65%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)199.20%

Management effectiveness

Return on assets (ttm)-22.93%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)17.53M
Revenue per share (ttm)0.19
Quarterly revenue growth (yoy)2,229.10%
Gross profit (ttm)N/A
EBITDA -59.88M
Net income avi to common (ttm)-132.7M
Diluted EPS (ttm)-0.930
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)210.07M
Total cash per share (mrq)1.39
Total debt (mrq)9.07M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.59
Book value per share (mrq)0.07

Cash flow statement

Operating cash flow (ttm)-40.65M
Levered free cash flow (ttm)315.72M